Newsroom

Learn about new clients, partners, research studies, patents, products, FDA clearances, go lives, special events and more by searching our comprehensive library of press releases. We welcome inquires from media.

Glytec Awarded First Patient Safety Solutions Agreement with Premier

Glytec named sole supplier of insulin management software for Premier’s network of more than 4,400 U.S. hospitals and 225,000 providers WALTHAM, MASS. (October 26, 2021) –Glytec – the only provider of cloud-based insulin management software across the continuum of care, today announced that it has been awarded a group purchasing agreement with Premier and will be the organization’s sole...
Read More

Healthcare Industry Leaders Unite Around Patient Safety at Glytec’s Inaugural Conference on Glycemic Innovation and Collaboration

Conference Identifies Key Strategies and Actionable Insights for Hospitals to Optimize Glycemic Management Ahead of New CMS Core Measures WALTHAM, MASS. (August 31, 2021) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today revealed details about its inaugural conference on glycemic innovation and collaboration, “Time to Target: Uniting...
Read More

Glytec Research Presented at American Diabetes Association’s 81st Scientific Sessions Shows Low Hypoglycemia for Adults with T1D Treated with eGlycemic Management System

Largest study to analyze T1D Patients With and Without DKA finds Glucommander insulin management software can safely keep blood glucose levels in range WALTHAM, MASS. (June 22, 2021) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today published the largest descriptive analysis of adult T1D patients with and without Diabetic ketoacidosis...
Read More

Glytec and ThunderCat Technology Partner to Improve Glycemic Management at VA Hospitals

Collaboration Seeks to Improve Outcomes and Reduce Cost of Care for the 25% of Veterans with Diabetes WALTHAM, MASS. (July 7, 2020) – Glytec, the only provider of insulin management software across the continuum of care, and ThunderCat Technology, a Service-Disabled Veteran-Owned Small Business (SDVOSB) that delivers technology products and services to government organizations, today announced a...
Read More

Glytec’s Glucommander Software Combined with Continuous Glucose Monitoring Enables Patients with Diabetes to Improve Time in Range by More than 25% in Only Four Weeks

First study to utilize CGM data with FDA-cleared, cloud-based titration software suggests significantly improved outcomes for patients while optimizing clinical resources WALTHAM, MASS. (June 16, 2020) – Glytec, the only provider of insulin management software across the continuum of care, today published the first proof-of-concept study that combines FDA-cleared remote insulin titration...
Read More

Healthcare Providers Showcase Value of Glytec’s Insulin Management Software During Diabetes Technology Society’s Virtual Hospital Poster Session

Event Includes Six Studies on Quality and Cost Improvements Achieved Through Glytec eGMS® WALTHAM, MASS. (June 11, 2020) – Glytec, the only provider of insulin management software across the continuum of care, announced today that healthcare providers from five separate health systems will present studies on the transformative effects of implementing its eGlycemic Management System (eGMS) during...
Read More

Healthcare Providers Share Results of Computer-Guided Insulin Dosing through Glytec During Diabetes Technology Society’s Virtual Hospital Meeting

AdventHealth and CHI Franciscan Lead Three-Part Session with Data on Quality and Cost Improvements Achieved Through Electronic Glucose Management WALTHAM, Mass. (April 22, 2020) – Glytec, the only provider of insulin management software across the continuum of care, announced today that AdventHealth and CHI Franciscan will lead a three-part session titled, “Computer-Guided Insulin Dosing” at...
Read More

COVID-19 Study Shows More than 4 Times In-Hospital Mortality Rate and Increased Length of Stay for Patients with Diabetes and Hyperglycemia

Glytec Research Reveals New Insights Into Important Risk Factors for the Large Population of COVID-19 Patients with Glycemic Control Issues WALTHAM, MASS. (April 17, 2020) – Glytec, the only provider of insulin management software across the continuum of care, today published an observational study on the impact of diabetes and uncontrolled hyperglycemia in hospitalized COVID-19 patients. The...
Read More